Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,621,000 | 13,451,000 | 13,531,000 | 10,900,000 | 9,311,000 |
| Marketable Securities | 1,865,000 | 2,690,000 | 1,441,000 | 1,301,000 | 293,000 |
| Receivables | 7,184,000 | 7,672,000 | 8,261,000 | 7,344,000 | 6,603,000 |
| Inventories | 6,226,000 | 6,535,000 | 6,254,000 | 5,868,000 | 8,048,000 |
| Income taxes - deferred | 4,789,000 | 4,509,000 | 3,694,000 | 3,651,000 | 4,177,000 |
| TOTAL | $35,685,000 | $34,857,000 | $33,181,000 | $29,064,000 | $28,432,000 |
| Non-Current Assets | |||||
| PPE Net | 14,973,000 | 16,030,000 | 16,297,000 | 17,082,000 | 18,279,000 |
| Investments And Advances | 9,770,000 | 7,305,000 | 3,458,000 | 2,175,000 | 432,000 |
| Intangibles | 36,102,000 | 41,217,000 | 46,457,000 | 51,834,000 | 59,795,000 |
| Other Non-Current Assets | 9,115,000 | 6,723,000 | 5,735,000 | 5,626,000 | 5,376,000 |
| TOTAL | $69,960,000 | $71,275,000 | $71,947,000 | $76,717,000 | $83,882,000 |
| Total Assets | $105,645,000 | $106,132,000 | $105,128,000 | $105,781,000 | $112,314,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,274,000 | 1,753,000 | 2,023,000 | 2,308,000 | 2,244,000 |
| Accrued Expenses | 9,501,000 | 9,737,000 | 10,170,000 | 8,514,000 | 9,455,000 |
| Other current liabilities | N/A | N/A | N/A | N/A | 207,000 |
| TOTAL | $17,868,000 | $18,348,000 | $16,245,000 | $15,641,000 | $15,641,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20,539,000 | 16,254,000 | 15,525,000 | 15,482,000 | 16,095,000 |
| Other Non-Current Liabilities | 8,023,000 | 10,196,000 | -120,000 | -121,000 | -123,000 |
| TOTAL | $35,451,000 | $32,321,000 | $31,940,000 | $33,335,000 | $35,188,000 |
| Total Liabilities | $53,319,000 | $50,669,000 | $48,185,000 | $48,976,000 | $50,829,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,940,622 | 3,022,367 | 3,044,008 | 3,083,081 | 3,115,317 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,781,000 |
| Retained earnings | 39,257,000 | 39,985,000 | 38,990,000 | 37,536,000 | 41,405,000 |
| Other shareholders' equity | 364,000 | -2,239,000 | -706,000 | -787,000 | -340,000 |
| TOTAL | $52,326,000 | $55,463,000 | $56,943,000 | $56,805,000 | $61,485,000 |
| Total Liabilities And Equity | $105,645,000 | $106,132,000 | $105,128,000 | $105,781,000 | $112,314,000 |